Phibro Animal Health Corp (PAHC) CEO Jack Bendheim Sells 10,000 Shares

Phibro Animal Health Corp (NASDAQ:PAHC) CEO Jack Bendheim sold 10,000 shares of the business’s stock in a transaction on Tuesday, June 19th. The stock was sold at an average price of $47.35, for a total transaction of $473,500.00. Following the completion of the transaction, the chief executive officer now owns 60,000 shares in the company, valued at approximately $2,841,000. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Jack Bendheim also recently made the following trade(s):

  • On Thursday, June 21st, Jack Bendheim sold 30,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $47.56, for a total transaction of $1,426,800.00.
  • On Monday, June 11th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $46.46, for a total transaction of $464,600.00.
  • On Wednesday, June 13th, Jack Bendheim sold 30,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $46.44, for a total transaction of $1,393,200.00.
  • On Thursday, June 7th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $46.47, for a total transaction of $464,700.00.
  • On Tuesday, June 5th, Jack Bendheim sold 10,000 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.87, for a total transaction of $458,700.00.

PAHC opened at $47.35 on Friday. The stock has a market capitalization of $1.93 billion, a PE ratio of 28.71, a P/E/G ratio of 2.85 and a beta of 0.94. Phibro Animal Health Corp has a 1-year low of $32.05 and a 1-year high of $48.40. The company has a quick ratio of 1.73, a current ratio of 3.17 and a debt-to-equity ratio of 1.61.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Monday, May 7th. The company reported $0.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.44 by $0.02. The company had revenue of $209.00 million during the quarter, compared to the consensus estimate of $203.03 million. Phibro Animal Health had a net margin of 7.24% and a return on equity of 39.91%. The company’s revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.37 EPS. equities analysts expect that Phibro Animal Health Corp will post 1.71 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 27th. Investors of record on Wednesday, June 6th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date of this dividend is Tuesday, June 5th. Phibro Animal Health’s dividend payout ratio is presently 26.49%.

Large investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. grew its position in shares of Phibro Animal Health by 17.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 476,391 shares of the company’s stock valued at $15,959,000 after buying an additional 69,063 shares during the last quarter. Prudential Financial Inc. grew its position in shares of Phibro Animal Health by 37.7% during the 1st quarter. Prudential Financial Inc. now owns 189,070 shares of the company’s stock valued at $7,506,000 after buying an additional 51,800 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its position in shares of Phibro Animal Health by 37.4% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 243,550 shares of the company’s stock valued at $8,159,000 after buying an additional 66,300 shares during the last quarter. Investors Research Corp bought a new stake in shares of Phibro Animal Health during the 4th quarter valued at about $433,000. Finally, Arizona State Retirement System grew its position in shares of Phibro Animal Health by 229.1% during the 4th quarter. Arizona State Retirement System now owns 32,914 shares of the company’s stock valued at $1,103,000 after buying an additional 22,914 shares during the last quarter. 48.50% of the stock is owned by institutional investors and hedge funds.

PAHC has been the subject of several research analyst reports. ValuEngine raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, February 28th. BidaskClub raised shares of Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Saturday, March 3rd. Zacks Investment Research downgraded shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, April 11th. Finally, Credit Suisse Group boosted their target price on shares of Phibro Animal Health from $39.00 to $42.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 9th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. Phibro Animal Health has a consensus rating of “Hold” and a consensus price target of $38.80.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply